Cardiovascular & Hematological Disorders-Drug Targets
Title:ACKNOWLEDGEMENTS
Volume: 12 Issue: 2
Export Options
About this article
Cite this article as:
ACKNOWLEDGEMENTS, Cardiovascular & Hematological Disorders-Drug Targets 2012; 12 (2) . https://dx.doi.org/10.2174/1871529X1120202000I
DOI https://dx.doi.org/10.2174/1871529X1120202000I |
Print ISSN 1871-529X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4063 |
Related Journals
Related Books
12
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Future Perspectives on the Fibrinolytic Therapy of Intracerebral Hemorrhages
Central Nervous System Agents in Medicinal Chemistry Relocation of Industrial Facilities Using Self-Propelled Modular Transporters (SPMT`S)
Recent Patents on Engineering Recent Patents on Needle Insertion Mechanism
Recent Patents on Engineering Design and Dynamic Simulation Research of a Bionic Three-Link Tube Shock Absorber
Recent Patents on Mechanical Engineering Genetics and Mitochondrial Abnormalities in Autism Spectrum Disorders:A Review
Current Genomics Glycogen Synthase Kinase-β3 in Ischemic Neuronal Death
Current Neurovascular Research Biologically Responsive Nanosystems Targeting Cardiovascular Diseases
Current Drug Delivery Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design Sex Differences and Emerging New Risk Factors for Atherosclerosis and Its Thrombotic Complications
Current Pharmaceutical Design Drug-Coated Balloons Applications in Interventional Cardiology
Current Pharmaceutical Design Evaluation Approach can Significantly Influence Oral Glucose-Lowering Drugs Total Mortality Risks in Retrospective Cohorts of Type 2 Diabetes Mellitus Patients
Current Diabetes Reviews Oral IIa and Xa Inhibitors for Prevention of Stroke in Atrial Fibrillation: Clinical Studies and Regulatory Considerations
Current Clinical Pharmacology Recent Developments on Endothelin Antagonists as Immunomodulatory Drugs - from Infection to Transplantation Medicine
Recent Patents on Cardiovascular Drug Discovery Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples
Current Drug Metabolism Advances and Patents about Medical Surgical Operation Bone Drilling Equipment
Recent Patents on Mechanical Engineering Transport of Cryptotanshinone, a Major Active Triterpenoid in Salvia Miltiorrhiza Bunge Widely Used in the Treatment of Stroke and Alzheimers Disease, Across the Blood-Brain Barrier
Current Drug Metabolism Complementary and Alternative Medicine for the Treatment of Insomnia: An Overview of Scientific Evidence from 2008 to 2018
Current Vascular Pharmacology Pain and Muscles Properties Modifications After Botulinum Toxin Type A (BTX-A) and Radial Extracorporeal Shock Wave (rESWT) Combined Treatment
Endocrine, Metabolic & Immune Disorders - Drug Targets The Mediterranean and other Dietary Patterns in Secondary Cardiovascular Disease Prevention: A Review
Current Vascular Pharmacology